Pentoxifylline 16571-0856
Product NDC
16571-0856- Manufacturer
- Rising Pharma Holdings, Inc.
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- June 11, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA074425
Need to source Pentoxifylline? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Pentoxifylline | 400 mg/1 |
Drug Class
Blood Viscosity Reducer [EPC]Blood Viscosity Reducer [EPC]Hematologic Activity Alteration [PE]
Packaging Options(3)
100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-856-01)
500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-856-50)
1 BLISTER PACK in 1 CARTON (16571-856-90) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK